亚太中风诊断市场，按严重程度（中度、重度、轻度）、类型（计算机断层扫描 (CT 扫描)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声、视频头部脉冲测试 (VHIT)、其他）、应用（缺血性中风、出血性中风、短暂性脑缺血发作 (TIAS)）、最终用户（医院、诊所、门诊手术中心、家庭医疗保健）、分销渠道（直接招标、第三方分销商、其他）、阶段（术前、术中、术后）、国家（日本、中国、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾和亚太其他地区）行业趋势和预测到 2028 年
市场分析与洞察：亚太地区中风诊断市场
预计亚太地区中风诊断市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 11.2%，预计到 2028 年将达到 69.6906 亿美元。慢性病和癌症的发病率上升是主要驱动因素，预计将在预测期内推动市场的需求。
当脑部血液供应减少或完全受阻时，就会发生中风，导致脑组织无法获得氧气和营养。目前有多种诊断设备可用于检测中风及其早期症状，例如计算机断层扫描 (CT SCAN)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声等。
中风、心血管和神经系统疾病的发病率不断上升，增加了发展中国家对中风诊断的需求。此外，医疗支出的增加也推动了市场的增长。另一方面，诊断的高成本可能会阻碍市场的增长。市场参与者的存在和新产品的推出为市场提供了机会。然而，缺乏熟练的专业人员可能会给市场带来挑战。
中风诊断市场报告提供了市场份额、新发展、国内和本地市场参与者的影响、新兴收入领域机会分析、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新的详细信息。要了解分析和市场情况，请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
亚太地区中风诊断市场范围和市场规模
亚太地区中风诊断市场根据严重程度、类型、应用、最终用户、分销渠道和阶段分为六个显著的部分。
- 根据严重程度，亚太地区中风诊断市场分为中度、重度和轻度。由于中风患者人数增加，预计 2021 年中度中风将占据市场主导地位。
- 根据类型，亚太地区中风诊断市场细分为计算机断层扫描 (CT 扫描)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声、视频头部脉冲测试 (VHIT) 等。由于心血管疾病的增加，预计 2021 年计算机断层扫描 (CT 扫描) 领域将占据市场主导地位。
- 根据应用，亚太地区中风诊断市场细分为缺血性中风、出血性中风和短暂性脑缺血发作 (TIAS)。随着全球缺血性中风发病率的增加，预计到 2021 年缺血性中风将占据市场主导地位。
- 根据终端用户，亚太地区中风诊断市场分为医院、家庭医疗保健、门诊手术中心和诊所。由于心血管和神经等慢性疾病的数量不断增加，预计 2021 年医院部门将占据市场主导地位。
- 根据分销渠道，亚太地区中风诊断市场分为直接招标、第三方分销商和其他。由于技术不断进步，预计 2021 年直接招标将占据市场主导地位。
- 根据阶段，亚太地区中风诊断市场分为术前、术中和术后。由于中风发病率不断上升，预计 2021 年术前诊断将占据市场主导地位。
中风诊断市场国家级分析
对中风诊断市场进行分析，并根据严重程度、类型、应用、最终用户、分销渠道和阶段提供市场规模信息。
中风诊断市场报告涵盖的国家包括日本、中国、澳大利亚、印度、韩国、新加坡、印度尼西亚、泰国、马来西亚、菲律宾和亚太地区其他国家。
由于中风诊断制造商数量不断增加，预计亚太地区中风诊断细分市场将在 2021 年至 2028 年的预测期内以最高增长率增长。日本引领亚太地区中风诊断市场的增长，由于该国火灾事件数量不断增加，预计医院细分市场将主导中风诊断细分市场。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。
FDA 批准的增加正在推动中风诊断市场的增长
中风诊断市场还为您提供每个国家中风诊断行业增长的详细市场分析，包括中风诊断药物销售、中风诊断技术进步的影响以及监管环境的变化及其对中风诊断市场的支持。数据涵盖 2011 年至 2019 年的历史时期。
竞争格局和中风诊断市场份额分析
中风诊断市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对中风诊断市场的关注有关。
- 在亚太地区中风诊断市场开展业务的主要公司有西门子、荷兰皇家飞利浦公司、通用电气公司、深圳迈瑞生物医疗电子股份有限公司、富士胶片控股株式会社、佳能公司、ALPINION 医疗系统有限公司、Analogic 公司、Aspect Imaging 有限公司、BPL 医疗技术公司、锐珂医疗、ESAOTE SPA、富士胶片控股株式会社、Hologic 公司、IMRIS、Deerfield Imaging 公司、Medfield Diagnostics AB、MEDTRON AG、东软集团、三星、深圳安科高科技股份有限公司、岛津制作所、SIUI、SternMed GmbH、史赛克等。
全球各地的公司也发起了许多产品发布和协议，这也加速了中风诊断市场的发展。
例如，
- 2021 年 2 月，荷兰皇家飞利浦公司宣布已成功完成对 BioTelemetry, Inc. 的收购，BioTelemetry 是一家领先的美国远程心脏诊断和监测提供商。此次收购帮助该公司在其产品线中增加了新的技术可穿戴传感产品
- 2021 年 5 月，通用电气公司宣布收购了 Zionexa，这是一家法国私营公司，开发和商业化可帮助医生诊断的成像剂。这有助于该公司增加其诊断工具
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略增强了公司在中风诊断市场的市场，这也有利于该组织改善其在中风诊断方面的产品。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC STROKE DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 EPIDEMIOLOGY
6 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATION IN CHINA
6.4 REGULATION IN JAPAN
6.5 REGULATION IN SOUTH AFRICA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASE IN THE INCIDENCE OF STROKE
7.1.3 INCREASE IN THE GERIATRIC POPULATION
7.1.4 INCREASE IN NUMBER OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASES
7.2 RESTRAINTS
7.2.1 HIGH COST OF DIAGNOSIS
7.2.2 INCREASE IN PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE SPENDING
7.3.2 INCREASE IN DIABETIC POPULATION AND OBESITY
7.3.3 INCREASE IN FDA APPROVAL AND PRODUCT LAUNCH
7.3.4 RISE IN AWARENESS REGARDING HEALTH AND STROKE
7.4 CHALLENGES
7.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO
7.4.2 COMPLICATION RELATED TO DIAGNOSTIC DEVICES
8 IMPACT OF COVID-19 ON ASIA PACIFIC STROKE DIAGNOSTICS MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC INITIATIVES
8.5 CONCLUSION
9 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY
9.1 OVERVIEW
9.2 MODERATE
9.3 SEVERE
9.4 MILD
10 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE
10.1 OVERVIEW
10.2 COMPUTED TOMOGRAPHY (CT SCAN)
10.3 COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA)
10.4 MAGNETIC RESONANCE IMAGING (MRI)
10.5 MAGNETIC RESONANCE ANGIOGRAPHY (MRA)
10.6 TRANSCRANIAL DOPPLER ULTRASOUND
10.7 VIDEO HEAD IMPULSE TEST (VHIT)
10.8 OTHERS
10.8.1 CAROTID ULTRASOUND
10.8.2 CAROTID ANGIOGRAPHY
10.8.3 ELECTROCARDIOGRAPHY (EKG)
10.8.4 ECHOCARDIOGRAPHY
10.8.5 BLOOD TESTS
10.8.6 NUCLEAR NEUROIMAGING
10.8.7 OTHERS
11 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ISCHEMIC STROKE
11.2.1 THROMBOTIC STROKES
11.2.2 EMBOLIC STROKES
11.3 HEMORRHAGIC STROKE
11.3.1 INTRACEREBRAL HEMORRHAGE
11.3.2 SUBARACHNOID HEMORRHAGE
11.4 TRANSIENT ISCHEMIC ATTACKS (TIAS)
12 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITAL
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 HOME HEALTHCARE
12.6 OTHERS
13 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
14 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE
14.1 OVERVIEW
14.2 PRE OPERATIVE
14.3 PERI OPERATIVE
14.4 POST OPERATIVE
15 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY REGION
15.1 ASIA-PACIFIC
15.1.1 JAPAN
15.1.2 CHINA
15.1.3 INDIA
15.1.4 SOUTH KOREA
15.1.5 AUSTRALIA
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 STROKE DIAGNOSTICS MARKET COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 SIEMENS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 KONINKLIJKE PHILIPS N.V.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 GENERAL ELECTRIC COMPANY
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 CANON INC
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 ALPINION MEDICAL SYSTEMS CO., LTD
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 ANALOGIC CORPORATION
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ASPECT IMAGING LTD
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 BPL MEDICAL TECHNOLOGIES
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 CARESTREAM HEALTH
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 ESAOTE SPA
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENTS
18.12 FONAR CORP
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENT
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 HOLOGIC, INC
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.15 IMRIS, DEERFIELD IMAGING INC.
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 MEDFIELD DIAGNOSTICS AB
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MEDTRON AG
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 NEUSOFT CORPORATION
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 SAMSUNG
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 SHENXHEN ANKE HIGH-TECH CO., LTD.
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
18.21 SHIMADZU CORPORATION
18.21.1 COMPANY SNAPSHOT
18.21.2 REVENUE ANALYSIS
18.21.3 PRODUCT PORTFOLIO
18.21.4 RECENT DEVELOPMENTS
18.22 SIUI
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 STERNMED GMBH
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 STRYKER
18.24.1 COMPANY SNAPSHOT
18.24.2 REVENUE ANALYSIS
18.24.3 PRODUCT PORTFOLIO
18.24.4 RECENT DEVELOPMENTS
18.25 TERASON DIVISION TERATECH CORPORATION
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 2 ASIA PACIFIC MODERATE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA PACIFIC SEVERE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 ASIA PACIFIC MILD IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT SCAN) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY (MRA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC TRANSCRANIAL DOPPLER ULTRASOUND IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC VIDEO HEAD IMPULSE TEST (VHIT) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC ISCHEMIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC HEMORRHAGIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC TRANSIENT ISCHEMIC ATTACKS (TIAS) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC HOSPITAL IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC CLINICS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC HOME HEALTHCARE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC DIRECT TENDER IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC PRE OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC PERI OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC POST OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 44 JAPAN STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 45 JAPAN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 JAPAN OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 JAPAN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 JAPAN ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 JAPAN HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 JAPAN STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 JAPAN STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 JAPAN STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 53 CHINA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 54 CHINA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 CHINA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 CHINA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 CHINA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 CHINA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CHINA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 CHINA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 CHINA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 62 INDIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 63 INDIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 INDIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 INDIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 INDIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 INDIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 INDIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 69 INDIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 INDIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 71 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 72 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH KOREA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 74 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 SOUTH KOREA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 SOUTH KOREA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 79 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 80 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 81 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 AUSTRALIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 AUSTRALIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 AUSTRALIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 88 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 89 SINGAPORE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 90 SINGAPORE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 91 SINGAPORE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 92 SINGAPORE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 93 SINGAPORE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 94 SINGAPORE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 95 SINGAPORE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 96 SINGAPORE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 97 SINGAPORE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 98 THAILAND STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 99 THAILAND STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 THAILAND OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 101 THAILAND STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 102 THAILAND ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 103 THAILAND HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 104 THAILAND STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 THAILAND STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 106 THAILAND STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 107 MALAYSIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 108 MALAYSIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 MALAYSIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 110 MALAYSIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 116 INDONESIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 117 INDONESIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 INDONESIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 INDONESIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 120 INDONESIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 125 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 126 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 PHILIPPINES OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 129 PHILIPPINES ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 130 PHILIPPINES HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 131 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 132 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 133 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 134 REST OF ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR STROKE DIAGNOSTISIS EXPECTED TO DRIVE THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET
FIGURE 15 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020
FIGURE 16 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020-2028 (USD MILLION)
FIGURE 17 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, CAGR (2021-2028)
FIGURE 18 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, 2020
FIGURE 20 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 21 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 22 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020
FIGURE 24 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 25 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 26 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, 2020
FIGURE 28 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 29 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 30 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 32 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 33 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 34 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, 2020
FIGURE 36 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, 2020-2028 (USD MILLION)
FIGURE 37 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, CAGR (2021-2028)
FIGURE 38 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: SNAPSHOT (2020)
FIGURE 40 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020)
FIGURE 41 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 42 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 43 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY (2021-2028)
FIGURE 44 STROKE DIAGNOSTICS MARKET COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
